BioLineRx In-Licenses Second Oral Hepatitis C Treatment

News   May 24, 2012

 
BioLineRx In-Licenses Second Oral Hepatitis C Treatment
 
 
 

RELATED ARTICLES

Commonly Prescribed Painkillers: What Can be Done to Reduce Risk of Obesity and Sleep Deprivation?

News

Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

READ MORE

Safer Opioids: Separating Pain Relieving Properties from Dangerous Side Effects

News

A group of researchers, led by Dr. Laura Bohn at The Scripps Research Institute, may have found a way to make opioids safer by separating the drugs' pain relieving effects from their most dangerous side effect, respiratory suppression, which, in very severe cases, causes patients to stop breathing and to die.

READ MORE

Chemists Have Synthesized New Isoquinoline Derivatives

News

Chemists have synthesized new isoquinoline derivatives. Due to their biological activity, these compounds may be applicable in new drugs, from antispasmodics to bactericidal agents. In addition, in the future they may show effectiveness in the treatment of Alzheimer's disease.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE